To understand the clinical relevance of SBSPON expression in bladder cancer, the relationship between SBSPON expression levels and the clinicopathological variables of bladder cancer patients was analyzed by using immunohistochemical staining on a bladder cancer high density tissue array and a bladder cancer survival tissue array with a validated antibody against SBSPON. The gene discussed is SBSPON; the disease is urinary bladder cancer.